Brand Name(s): Nizoral
CAS nº: 65277-42-1
(kee-toe-koe-na-zole)
About Ketoconazole
This reference site is dedicated exclusively to ketoconazole.
It provides you with the most extensive product information and up-to-date resources regarding this medication, including related news articles, medical studies, an image library and all the necessary information on dosage and side effects.
Whether you are an average consumer or a pharma industry professional, you can now find out everything you need to know about ketoconazole, as well as take part in our open discussion forum by sharing your own knowledge and experiences with people who are using this medication.
This unique site will also provide you with inside industry news on which companies or organizations are playing an important part in its research, development, production and promotion. It is your one-stop site for a total ketoconazole experience!
Why is this medication prescribed?
Ketoconazole is in a class of antifungals called imidazoles. It works by slowing the growth of fungi that cause infection.
It is used to treat yeast infections of the mouth, throat, and esophagus, as well as fungal infections throughout the whole body and serious fungal infections of the skin and nails.
The over-the-counter shampoo version of ketoconazole can also be used as a body wash for the treatment of tinea versicolor.
Latest News
Barrier Therapeutics Announces Agreement with Procter & Gamble to Market Xolegel (ketoconazole, USP) Gel, 2 Percent With Head & Shoulders Shampoo as Xolegel Duo
Barrier Therapeutics, Inc., a pharmaceutical company developing and commercializing products in the...
[more]Johnson & Johnson launches Nizoral 100 ml bottles in India
Janssen-Cilag, a division of Johnson & Johnson Ltd. India, has announced the launch of Nizoral ™...
[more]Anti-fungal agent that curbed cocaine use in rodents has opposite effect in humans
Ketoconazole, an anti-fungal agent that helps curb cocaine use in laboratory rats, stimulates...
[more]DiObex Takes Novel Cortisol Synthesis Inhibitor Into Phase 2 Clinical Trial
DiObex, Inc., a privately-held pharmaceutical company focused on the development of therapeutics to...
[more]Barrier Therapeutics Announces FDA Acceptance of Its New Drug Application for Sebazole(TM) Topical Gel
Barrier Therapeutics, Inc. (NasdaqNM:BTRX ), a pharmaceutical company developing and...
[more]